EDDM3B

Across TCGA pan-cancer cohorts, EDDM3B Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated EDDM3B data layer compared with 13 for mass-spec protein.

The strongest signal is observed in brain lower grade glioma (LGG), where higher EDDM3B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated EDDM3B expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LGG, SKCM, and UCEC are the cancer types where EDDM3B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Median	All	0.034	0.909	<.001	12	view →
SKCM	OS	Median	All	0.264	0.784	<.001	12	view →
UCEC	DFS	Median	All	1.000	0.631	.039	2	view →
LUSC	OS	Median	All	0.501	0.762	.037	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

EDDM3B–LGG (OS)

Open the LGG breakdown →